Morning Briefing
Summaries of health policy coverage from major news organizations
Pharma Scores A Victory With New Jersey Supreme Court's Ruling On Product Liability Litigation
Stat: New Jersey Court Gives Pharma A Boost In Consumer Lawsuits
In a closely watched decision, the New Jersey Supreme Court ruled that higher federal standards of evidence should be applied in product liability litigation, giving a boost to drug makers because so many lawsuits are filed in the state by people who claim they were harmed by medicines. The ruling came in a long-running case involving a Roche (RHHBY) acne drug that was blamed for causing Crohn’s disease in more than 2,100 lawsuits filed against the drug maker. (Silverman, 8/3)
In other pharmaceutical news —
NPR: A Marijuana-Based Medication Prevents Seizures For Some Epilepsy Patients
The first prescription medication extracted from the marijuana plant is poised to land on pharmacists' shelves this fall. Epidiolex, made from purified cannabidiol, or CBD, a compound found in the cannabis plant, is approved for two rare types of epilepsy. Its journey to market was driven forward by one family's quest to find a treatment for their son's epilepsy. (McClurg, 8/6)
